Pfizer raised its forecast for annual sales of its COVID vaccine to $34 billion on demand for Omicron-targeted boosters, helping allay some investor worries over growth for the vaccinations https://t.co/khCyXf5Peg pic.twitter.com/Ih8QSZTcnV— Reuters (@Reuters) November 1, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


